Ponad 7000 publikacji medycznych!
Statystyki za 2021 rok:
odsłony: 8 805 378
Artykuły w Czytelni Medycznej o SARS-CoV-2/Covid-19

Poniżej zamieściliśmy fragment artykułu. Informacja nt. dostępu do pełnej treści artykułu tutaj
© Borgis - New Medicine 1/2014, s. 26-28
*Konrad Wroński1,2
Prophylactic gastroenterostomy in patient with unresectable pancreatic head cancer – case report
1Faculty of Medicine, Department of Oncology, University of Warmia and Mazury, Olsztyn, Poland
Head of Department of Oncology: prof. Sergiusz Nawrocki, MD, PhD
2Department of Surgical Oncology, Hospital Ministry of Internal Affairs with Warmia and Mazury Oncology Centre, Olsztyn, Poland
Head of Department of Surgical Oncology: Andrzej Lachowski, MD
Summary
Optimal treatment patients with unresectable pancreatic head cancer is still a matter of debate for several reasons. The number of patients with unresectable pancreatic head cancer is increasing and their optimal treatment is a growing economic problem for health care. In this article the author presented a case of a man who was admitted to the hospital because of unresectable pancreatic head cancer. The patient underwent prophylactic gastroenterostomy and in the fifth day after surgery was discharged home.
INTRODUCTION
Optimal treatment patients with unresectable pancreatic head cancer is still a matter of debate for several reasons (1, 2). First reason: it is difficult to predict the number of patients who will suffer from duodenal obstruction, and second reason is possible complications after gastroenterostomy (1-5). The number of patients with unresectable pancreatic head cancer is increasing and their optimal treatment is a growing economic problem for health care (4-7).
CASE REPORT
A 58-year-old man, Caucasian race, was admitted to the Department of Surgical Oncology because of pancreatic head tumor. The patient did not eat the food for last 10 days, drank only water. Within a month, he lost about 10 kg. He had history of alcohol consumption about 80-120 gram/day for 10 years and he was heavy smoker – 15 cigarette/day for 20 years. In the past the patient have had pancreatitis twice and did not claim any additional diseases.
Blood examination of the patient showed raised results of amylase and lipase results and low levels of albumin and total protein. Other laboratory tests were normal.
On physical examination, in the epigastrium area a tumor was palpable. CT examination showed a pathological mesogastric lumpy mass in the region of the descending duodenum and the head of the pancreas, the size of tumor was approximately 50 x 58 x 42 mm, with cystic spaces and small, individual calcifications. The rest of the pancreas was not enlarged, even atrophic, but with a prominent extended to approximately 6 mm pancreatic duct in the stem of the pancreas and less clearly in its tail (fig. 1). A tumor of the pancreatic head infiltrated and compressed the duodenum causing obstruction of the upper gastrointestinal tract (fig. 2).
Fig. 1. CT image showed the large pancreatic tumor (diameter 50 x 58 x 42 mm) infiltrating and compression of the duodenum.
Fig. 2. CT image showed the residual contents of the stomach caused by obstruction of the duodenum. Duodenal obstruction was caused by infiltration and compression of the duodenum by the pancreatic tumor.

Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.
Mam kod dostępu
  • Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu albo wszystkich artykułów (w zależności od wybranej opcji), należy wprowadzić kod.
  • Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.
  • Aby kupić kod proszę skorzystać z jednej z poniższych opcji.

Opcja #1

19

Wybieram
  • dostęp do tego artykułu
  • dostęp na 7 dni

uzyskany kod musi być wprowadzony na stronie artykułu, do którego został wykupiony

Opcja #2

49

Wybieram
  • dostęp do tego i pozostałych ponad 7000 artykułów
  • dostęp na 30 dni
  • najpopularniejsza opcja

Opcja #3

119

Wybieram
  • dostęp do tego i pozostałych ponad 7000 artykułów
  • dostęp na 90 dni
  • oszczędzasz 28 zł
Piśmiennictwo
1. Sarr MG, Cameron JL: Surgical management of unresectable carcinoma of the pancreas. Surgery 1982; 91: 123-133. 2. Jacobs PP, van der Sluis RF, Wobbes T: Role of gastroenterostomy in the palliative surgical treatment of pancreatic cancer. J Surg Oncol 1989; 42: 145-149. 3. Hwang SI, Kim HO, Son BH et al.: Surgical palliation of unresectable pancreatic head cancer in elderly patients. World J Gastroenterol 2009; 15: 978-982. 4. Huser N, Michalski CW, Schuster T et al.: Systematic review and meta-analysis of prophylactic gastroenterostomy for unresectable advanced pancreatic cancer. Br J Surg 2009; 96: 711-719. 5. Shyr YM, Su CH, Wu CW, Lui WY: Prospective study of gastric outlet obstruction in unresectable periampullary adenocarcinoma. World J Surg 2000; 24: 60-64. 6. Lillemoe KD, Cameron JL, Hardacre JM et al.: Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999; 230: 322-338. 7. van der Schelling GP, van den Bosch RP, Klinkenbij JH et al.: Is there a place for gastroenterostomy in patients with advanced cancer of the head of the pancreas? World J Surg 1993; 17: 128-132. 8. Krzakowski M, Warzocha K: Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych 2013 rok. Gdańsk 2013. 9. Horstmann O, Kley CW, Post S, Becker H: Cross-section gastroenterostomy in patients with irresectable periampullary carcinoma. HPB (Oxford) 2001; 3: 157-163. 10. Muniraj T, Barve P: Laparoscopic staging and surgical treatment of pancreatic cancer. N AM J Med Sci 2013; 5: 1-9.
otrzymano: 2014-01-08
zaakceptowano do druku: 2014-02-19

Adres do korespondencji:
*Konrad Wroński
General Surgery Consultant Faculty of Medicine, Department of Surgical Oncology University of Warmia and Mazury, Olsztyn, Poland
37 al. Wojska Polskiego St., 10-228 Olsztyn
tel.: +48 505-818-126
e-mail: konradwronski@wp.pl

New Medicine 1/2014
Strona internetowa czasopisma New Medicine